<p>A) CD3, CD4 and CD8-expressing splenocytes were quantified by flow cytometry at the indicated time points following irradiation and lymphocyte infusion. Typical numbers from normal mice are indicated by the dotted line. Results shown from one of two experiments with similar results. B) Regulatory T cell splenocytes (CD3<sup>+</sup>CD4<sup>+</sup>Foxp3<sup>+</sup>) and the CD8<sup>+</sup> T cell to regulatory T cell ratio were quantified by flow cytometry. Expression of IL-15Rα and CD122 on tetramer<sup>+</sup> CD8<sup>+</sup> T cells was also quantified by flow cytometry. Results shown from one of two experiments with similar results. C) Mice were irradiated, received an infusion of 30×10<sup>6</sup> splenocytes from naïve Pmel mice, whi...
<p>BALB/c mice were sacrificed 24h after irradiation, non-irradiated mice served as controls, and T ...
<p>Groups of 5 FVB/N mice were primed IP with 2×10<sup>7</sup> 3604 or FVB/N splenocytes. Four weeks...
<div><p>There is clinical interest in the modulation of regulatory T cells for cancer therapy. The s...
<p>A) Mice were treated with radiation and lymphocyte infusion, and were then immunized with VP22-Op...
The development of successful cancer vaccines is contingent on the ability to induce effective and p...
<p>Splenocytes from mice vaccinated with mp53 DNA and incubated with mp53-iTC-1 or mp53-iTC-1/CD40L ...
<p>Mononuclear cells were obtained from the spleen of sham or gamma irradiated (2 Gy) mice at the in...
<p>A) Mice were treated with irradiation and lymphocyte infusion, and splenic dendritic cell (DC) (C...
<p>(A) Schematic diagram depicting the adoptive transfer and vaccination schedule. After C57BL/6 mic...
T cells are continuously moving through tissues and recirculating back into the peripheral blood via...
<p>(A) Flow cytometry analysis. Groups of C57BL/6 mice were injected with rat IgG, anti-CD4 or anti-...
<p>(<b>A</b>) Wild-type (WT) and CIITA<sup>Tg</sup>PIV<sup>KO</sup> host mice (Thy1.2<sup>+</sup>) w...
<p>Tumor cells were infected with VV-VSV-Np<sub>52–59</sub> overnight and were γ-irradiated. The cel...
<p>B6-LY5.2/Cr mice were irradiated at 500 rad. 24 h post irradiation, the mice were adoptively tran...
<p>C57BL/6 mice (6/group) were immunized twice (days 0 and 14) with HBSS (control) or irradiated 1×1...
<p>BALB/c mice were sacrificed 24h after irradiation, non-irradiated mice served as controls, and T ...
<p>Groups of 5 FVB/N mice were primed IP with 2×10<sup>7</sup> 3604 or FVB/N splenocytes. Four weeks...
<div><p>There is clinical interest in the modulation of regulatory T cells for cancer therapy. The s...
<p>A) Mice were treated with radiation and lymphocyte infusion, and were then immunized with VP22-Op...
The development of successful cancer vaccines is contingent on the ability to induce effective and p...
<p>Splenocytes from mice vaccinated with mp53 DNA and incubated with mp53-iTC-1 or mp53-iTC-1/CD40L ...
<p>Mononuclear cells were obtained from the spleen of sham or gamma irradiated (2 Gy) mice at the in...
<p>A) Mice were treated with irradiation and lymphocyte infusion, and splenic dendritic cell (DC) (C...
<p>(A) Schematic diagram depicting the adoptive transfer and vaccination schedule. After C57BL/6 mic...
T cells are continuously moving through tissues and recirculating back into the peripheral blood via...
<p>(A) Flow cytometry analysis. Groups of C57BL/6 mice were injected with rat IgG, anti-CD4 or anti-...
<p>(<b>A</b>) Wild-type (WT) and CIITA<sup>Tg</sup>PIV<sup>KO</sup> host mice (Thy1.2<sup>+</sup>) w...
<p>Tumor cells were infected with VV-VSV-Np<sub>52–59</sub> overnight and were γ-irradiated. The cel...
<p>B6-LY5.2/Cr mice were irradiated at 500 rad. 24 h post irradiation, the mice were adoptively tran...
<p>C57BL/6 mice (6/group) were immunized twice (days 0 and 14) with HBSS (control) or irradiated 1×1...
<p>BALB/c mice were sacrificed 24h after irradiation, non-irradiated mice served as controls, and T ...
<p>Groups of 5 FVB/N mice were primed IP with 2×10<sup>7</sup> 3604 or FVB/N splenocytes. Four weeks...
<div><p>There is clinical interest in the modulation of regulatory T cells for cancer therapy. The s...